Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages

Authors

Hemanth K Potluri, University of Wisconsin-Madison
Tun Lee Ng, University of Wisconsin-Madison
Michael A Newton, University of Wisconsin-Madison
Jin Zhang, Washington University School of Medicine in St. Louis
Christopher A Maher, Washington University School of Medicine in St. Louis
Peter S Nelson, Fred Hutchinson Cancer Research Center
Douglas G McNeel, University of Wisconsin-Madison

Journal

Journal for Immunotherapy of Cancer

Publication Date

12-1-2020

Volume

8

Issue

2

First Page

e001510

Document Type

Open Access Publication

DOI

10.1136/jitc-2020-001510

Rights and Permissions

Potluri HK, Ng TL, Newton MA, et alAntibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stagesJournal for ImmunoTherapy of Cancer 2020;8:e001510. doi: 10.1136/jitc-2020-001510 https://jitc.bmj.com/content/8/2/e001510 Copyright 2021 The Authors This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.

Recommended Citation

Potluri, Hemanth K; Ng, Tun Lee; Newton, Michael A; Zhang, Jin; Maher, Christopher A; Nelson, Peter S; and McNeel, Douglas G, "Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages." Journal for Immunotherapy of Cancer. 8, 2. e001510 (2020).
https://digitalcommons.wustl.edu/oa_4/114